{
    "eid": "2-s2.0-85124988656",
    "title": "Complicated bleeding challenge and intraoperative safety strategies in a case of hemophilia a with rhabdomyosarcoma",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pediatrics, Perinatology and Child Health",
            "@code": "2735",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "pharmacokinetic-guided prophylaxis",
        "pre-operative management",
        "rhabdomyosarcoma",
        "Severe hemophilia A"
    ],
    "authors": [
        "Phumin Chaweephisal",
        "Hansamon Poparn",
        "Kanhatai Chiengthong",
        "Panya Seksarn",
        "Piti Techavichit",
        "Supanun Lauhasurayotin",
        "Darintr Sosothikul"
    ],
    "citedby-count": 1,
    "ref-count": 8,
    "ref-list": [
        "A rare case of hemophilia with Ewing\u2019s sarcoma\u2013a case report",
        "Rhabdomyosarcoma: review of the Children\u2019s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies",
        "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children\u2019s oncology group study D9803",
        "Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A",
        "Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding",
        "Monitoring rFVIII prophylaxis dosing using global haemostasis assays",
        "Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections",
        "Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Special Task Force for Activating Research",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}